2025 first_quarter Filing

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INCforUnknown

Expenses

$1.2M

Method: A

Filed

April 21, 2025

View Original Document

Lobbying Activities

AnimalsView all

Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)

Contacted:Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Health IssuesView all

Issues related to prescription drug pricing and value Prescription drug manufacturing and supply chains Issues related to 340B program Issues related to tax and tariffs Issues related to Intellectual Property Issues related to Inflation Reduction Act

Contacted:HOUSE OF REPRESENTATIVES, SENATE

Lobbyists (5)

SARAH ELIZABETH NORDSTROM

ms KATHARINE TROLLER BOND

CHRISTOPHER CUNNINGHAM

BILL DAVIS